Low Incidence of Abacavir Hypersensitivity Reaction Among African Children Initiating Antiretroviral Therapy.

From:
Department for International Development
Published
1 January 2010
Country:
Uganda and Zimbabwe
Document Type:
Journal Article
Theme:
Health
Authors:
Mugyenyi, P., Munderi, P., Naidoo, B., Nahirya-Ntege, P. and Kekitiinwa, A.
Show 5 more
Bwakura-Dangarembizi, M.F., Musiime, V., Bakeera-Kitaka, S., Crawley, J., and Nathoo, K.

Abstract

Hypersensitivity reactions are reported in approximately 5% of adults receiving abacavir, but there are few published data in children. Among 1150 children in Uganda and Zimbabwe receiving antiretroviral therapy for HIV in a randomized trial, suspected hypersensitivity reactions to abacavir were rare (0.3%; 95% CI, 0.01-0.9). Patients were managed successfully through the provision of clear guidelines and education of clinical staff, children, and their caregivers.

Citation

The Pediatric Infectious Disease Journal (2010), published online before print, 15 December 2010 [doi:10.1097/INF.0b013e3182076864]

Low Incidence of Abacavir Hypersensitivity Reaction Among African Children Initiating Antiretroviral Therapy.

Updates to this page

Published 1 January 2010
Contents